Frontlight ResearchEarly access
Trial site
KaRa Institute of Neurological Diseases
- 5running trials
- 2closed trials
The trials here
What the 7 trials at this site are about, from their registry records.
- Conditions
- Alzheimer disease7 trials
- Mild cognitive impairment3 trials
- Phase
- Phase 36 trials
- Phase 21 trial
- Status
- Active, not recruiting3 trials
- Recruiting2 trials
- Terminated2 trials
- Lead sponsor
- Hoffmann-La Roche3 trials
- Biogen2 trials
- Eisai Inc.1 trial
- Janssen Pharmaceutica N.V., Belgium1 trial
Running trials
Recruiting
Active, not recruiting
A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
Recruiting
Active, not recruiting
A Study of JNJ-64042056 in Participants With Preclinical Alzheimer's Disease
Active, not recruiting
A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's Disease
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Alzheimer disease2 recruiting
- Mild cognitive impairment1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 17 Nov 2026